Trial Profile
Ascending Single Dose Study Of The Safety, Tolerability And Pharmacokinetics Of SAM-760 Administered Orally To Healthy Young And Healthy Elderly Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2013
Price :
$35
*
At a glance
- Drugs PF 5212377 (Primary) ; Ketoconazole
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 21 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.